CJ Bioscience Overview
- Year Founded
-
2009
- Status
-
Public
- Employees
-
139
- Stock Symbol
-
311690
- Investments
-
1
- Share Price
-
$7.82
- (As of Friday Closing)
CJ Bioscience General Information
Description
CJ Bioscience Inc is engaged in directing a healthy life based on microbiological research. It presents directions and solutions to all fields of research on the microbiome, such as academia in the bioinformatics field, R&D centers of hospitals and research institutes, and NGS (next-generation sequencing) service companies. Its services includes NGS, EZBioCloud, Healthcare among others.
Contact Information
Website
www.cjbioscience.comCorporate Office
- Grand Central, 14, Sejong-daero
- Jung-gu
- Seoul, 04527
- South Korea
Corporate Office
- Grand Central, 14, Sejong-daero
- Jung-gu
- Seoul, 04527
- South Korea
CJ Bioscience Timeline
CJ Bioscience Stock Performance
As of 13-Dec-2024, CJ Bioscience’s stock price is $7.82. Its current market cap is $71.3M with 9.1M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $7.82 | $7.27 | $5.85 - $13.43 | $71.3M | 9.1M | 266K | -$1.45 |
CJ Bioscience Financials Summary
As of 30-Sep-2024, CJ Bioscience has a trailing 12-month revenue of $2.95M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 57,890 | 113,538 | 193,155 | |
| Revenue | 2,948 | 4,264 | 3,153 | 3,809 |
| EBITDA | (13,608) | (13,930) | (22,894) | (11,483) |
| Net Income | (16,065) | (17,525) | (27,020) | (16,826) |
| Total Assets | 51,354 | 70,715 | 72,364 | 97,776 |
| Total Debt | 6,492 | 6,622 | 22,936 | 20,076 |
CJ Bioscience Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CJ Bioscience Comparisons
Industry
Financing
Details
CJ Bioscience Competitors (24)
One of CJ Bioscience’s 24 competitors is Genewiz, a Formerly VC-backed company based in South Plainfield, NJ.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Genewiz | Formerly VC-backed | South Plainfield, NJ | ||||
| Molecular Cloning Laboratories | Corporation | South San Francisco, CA | ||||
| Eurofins Genomics Americas | Corporation | Louisville, KY | ||||
| Oxford Gene Technology | Formerly VC-backed | Begbroke, United Kingdom | ||||
| SeqLL | Formerly VC-backed | Billerica, MA |
CJ Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
CJ Bioscience Patents
CJ Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200234792-A1 | Method for obtaining microorganism information using tetra-nucleotide frequency | Inactive | 22-Feb-2017 | ||
| EP-3511847-A1 | Method for obtaining ribosomal rna (rrna) sequence information and method for identifying microorganism using rrna | Inactive | 27-Dec-2016 | ||
| US-20190119717-A1 | Ribosomal rna sequence extraction method and microorganism identification method using extracted ribosomal rna sequence | Inactive | 27-Dec-2016 | ||
| EP-3511847-A4 | Method for obtaining ribosomal rna (rrna) sequence information and method for identifying microorganism using rrna | Inactive | 27-Dec-2016 | C12Q1/04 |
CJ Bioscience Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
CJ Bioscience Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
CJ Bioscience Investments (1)
CJ Bioscience’s most recent deal was a Corporate Asset Purchase with 4D Pharma (15 Microbiome Drug Pipelines in Leeds, United Kingdom). The deal was made on 04-May-2023.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 4D Pharma (15 Microbiome Drug Pipelines in Leeds, United Kingdom) | 04-May-2023 | Corporate Asset Purchase | Buildings and Property |
CJ Bioscience FAQs
-
When was CJ Bioscience founded?
CJ Bioscience was founded in 2009.
-
Where is CJ Bioscience headquartered?
CJ Bioscience is headquartered in Seoul, South Korea.
-
What is the size of CJ Bioscience?
CJ Bioscience has 139 total employees.
-
What industry is CJ Bioscience in?
CJ Bioscience’s primary industry is Biotechnology.
-
Is CJ Bioscience a private or public company?
CJ Bioscience is a Public company.
-
What is CJ Bioscience’s stock symbol?
The ticker symbol for CJ Bioscience is 311690.
-
What is the current stock price of CJ Bioscience?
As of 13-Dec-2024 the stock price of CJ Bioscience is $7.82.
-
What is the current market cap of CJ Bioscience?
The current market capitalization of CJ Bioscience is $71.3M.
-
What is CJ Bioscience’s current revenue?
The trailing twelve month revenue for CJ Bioscience is $2.95M.
-
Who are CJ Bioscience’s competitors?
Genewiz, Molecular Cloning Laboratories, Eurofins Genomics Americas, Oxford Gene Technology, and SeqLL are some of the 24 competitors of CJ Bioscience.
-
What is CJ Bioscience’s annual earnings per share (EPS)?
CJ Bioscience’s EPS for 12 months was -$1.45.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
